Just to jump in on the conversation.
There may well end up being one OBD for IT (injected into the tumour) and another for IV (into the bloodstream). With IV being higher due to its dispersal.
I believe they're quite keen to pump the IV rates to see how high they can go due to the convenience and also the body wide effectiveness and possible access to diffic ult to reach tumours.
Provided they can get it to be nicely effective at higher doses. Which I'm relatively confident in based on trial to date results.
Just my thoughts. I'll go back to lurking and ignoring.
Just to jump in on the conversation. There may well end up being...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.7¢ |
Change
0.005(5.49%) |
Mkt cap ! $633.1M | |||
| Open | High | Low | Value | Volume |
| 8.2¢ | 8.7¢ | 8.1¢ | $1.710M | 20.16M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 2165590 | 8.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.7¢ | 373738 | 10 |
View Market Depth
| Last trade - 14.02pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
8.7¢ |
Change
0.005 ( 5.84 %) |
||||
| Open | High | Low | Volume | ||
| 8.2¢ | 8.7¢ | 8.2¢ | 6420381 | ||
| Last updated 14.23pm 30/04/2024 ? | |||||
| IMU (ASX) Chart |